




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Atrial Fibrillation/Supraventricular Arrhythmias</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=9d928ff7-0a69-4d5c-8ae4-9a5be446fc6b</link>
        <description>Clinical Topic Feed: Atrial Fibrillation/Supraventricular Arrhythmias</description>
        <language>en</language>

        

                <item>
                    <title>Does Influenza Vaccination Reduce AFib Risk?</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/07/22/17/25/Influenza-Vaccination</link>                    <description>Influenza vaccination was associated with lower risks of incident atrial fibrillation (AFib) and multiple cardiovascular outcomes, according to an observational cohort study published July 11 in EHJ. The findings support vaccination as a potential AFib prevention strategy and underscore the need for randomized trials focused on AFib-related outcomes.</description>
                    <pubdate>1784742720000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>The Importance of Enhanced Radiation Protections in Cath Labs</title>
<link>/Latest-in-Cardiology/Articles/2026/07/22/13/15/eagles-eye-view-22jul2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at age, body mass index (BMI), and cardiovascular outcomes after transcatheter aortic valve replacement (TAVR).</description>
                    <pubdate>1784726220000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Multisociety Statement Calls For Enhanced Radiation Protection in Cath Labs</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/07/15/17/28/Multisociety-Statement</link>                    <description>A new expert consensus statement calls for the immediate adoption of safer technologies that are now available to protect health care professionals performing minimally invasive procedures in cath labs from the well-known and preventable hazards of radiation exposure and orthopedic injuries.</description>
                    <pubdate>1784137320000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#39;s Eye View: The SHaRE Registry as a Predictor of MACE</title>
<link>/Latest-in-Cardiology/Articles/2026/07/15/14/19/eagles-eye-view-15jul2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at the feasibility of mechanical leaflet splitting in high-risk patients undergoing valve-in-valve transcatheter aortic valve replacement (TAVR).</description>
                    <pubdate>1784125200000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACCEL Lite: Managing Subclinical AFib Detected by Devices, Ambulatory Monitors and Wearables</title>
<link>/Latest-in-Cardiology/Articles/2026/07/14/13/32/accel-lite-14july2026</link>                    <description>In this interview, W. Douglas Weaver MD, MACC and Deepak Bhakta, MD, MBA, FACC discuss managing subclinical AFib detected by devices, ambulatory monitors and wearables.</description>
                    <pubdate>1784036040000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Safety of Antiarrhythmic Agents in Breastfeeding Women</title>
<link>/Latest-in-Cardiology/Articles/2026/07/07/14/25/Safety-of-Antiarrhythmic-Agents-in-Breastfeeding-Women</link>                    <description>According to the American Academy of Pediatrics (APA) and the World Health Organization (WHO), exclusive breastfeeding is recommended for the first 6 months of infant life, with continuation up to 2 years or as long as mutually desired by the lactating individual and infant.</description>
                    <pubdate>1783940280000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>SHaRe Registry Identifies MACE Predictors in Mild HCM</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/07/07/13/29/SHaRe-Registry</link>                    <description>About one in five patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events (MACE) over seven years of follow-up, according to SHaRe Registry research published July 8 in JACC.</description>
                    <pubdate>1783532640000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>PFA Matches RFA on PVI Durability, Shows Low AE Rates in Registry Data</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/07/07/13/29/PFA-Matches-RFA</link>                    <description>Two studies published in JACC: Clinical Electrophysiology on June 29 provide new insights on the durability of pulmonary vein isolation (PVI) with pulsed field ablation (PFA) vs. radiofrequency ablation (RFA) in patients with persistent atrial fibrillation (AFib), as well as the safety profile of PFA among patients undergoing their first ablation for AFib.</description>
                    <pubdate>1783520340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Can Sugar-Sweetened Beverages and Fruit Juice Lead to Hypertension?</title>
<link>/Latest-in-Cardiology/Articles/2026/07/08/14/16/eagles-eye-view-08jul2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at withdrawing guideline-directed medical therapy (GDMT) for patients with atrial fibrillation (AF).</description>
                    <pubdate>1783520220000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Discontinuation of Anticoagulation Following Catheter Ablation of AF: Updates With OCEAN Trial</title>
<link>/Latest-in-Cardiology/Articles/2026/06/29/15/28/Discontinuation-of-Anticoagulation</link>                    <description>Current guidelines for management of atrial fibrillation (AF) recommend continuation of oral anticoagulation (OAC) following successful catheter ablation of AF for patients deemed at elevated thromboembolic risk.</description>
                    <pubdate>1782921180000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>